Divalproex Sodium Tablet, Delayed Release
Product Images NDC 71335-0008

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 71335-0008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 01

Chemical structure diagram of Divalproex Sodium, showing the molecular arrangement with associated chemical groups including carbon chains and sodium ions.*

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 02

A bar chart comparing percentage values across two studies (Study 1 and Study 2). Each study shows two bars labeled PBO and DVPX, with DVPX bars notably higher than PBO bars, illustrating a comparison of outcomes between placebo and Divalproex Sodium treatment groups.*

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 03

A line graph comparing the percentage reduction in CPS rate between Divalproex Sodium and placebo across a percentage of patients. The vertical axis shows percentage reduction in CPS rate ranging from -100% (worsening) to 100% (improvement). The horizontal axis represents the percentage of patients from 100% to 0%. Two curves are shown: a solid line for Divalproex Sodium and a dashed line for placebo, indicating varying levels of reduction and improvement.*

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 04

A line graph showing the percentage reduction in CPS rate by percentage of patients, comparing high dose (solid line) and low dose (dashed line) Divalproex Sodium. The vertical axis ranges from -100% (worsening) to 100% (improvement), illustrating patient response distribution.*

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 05

A bar chart comparing the effects of Placebo and Divalproex Sodium in two separate studies labeled Study 1 and Study 2. The vertical axis measures an unspecified variable ranging approximately from 0 to 6. In both studies, the placebo bars are higher than the Divalproex Sodium bars.*

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 06

FDA Label Image

Label Image (Lbl713350008)

Label for Divalproex Sodium DR 250 mg delayed-release tablets by Bryant Ranch Prepack, packaging of 30 tablets. It compares to Depakote 250 mg tablets by Unichem Laboratories Ltd. Includes storage instructions (20°-25°C) and a barcode. NDC 71335-0008 shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.